Fuchao Ma
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- RNA Research and Splicing
- Circular RNAs in diseases
- Cell death mechanisms and regulation
Papers in
-
- RNA modifications and cancer 8
- RNA Research and Splicing 4
- Circular RNAs in diseases 2
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 6
- Co-authors
- Gang Chen (14 shared papers)Rong‐Quan He (12 shared papers)Xiaohua Hu (9 shared papers)Zu-yun Li (2 shared papers)Dandan Xiong (2 shared papers)Lu Liang (1 shared paper)Dianzhong Luo (1 shared paper)Peng Lin (3 shared papers)
- Journals
- Oncology Reports (2 papers)PeerJ (2 papers)Acta Pharmaceutica Sinica B (1 paper)Medicine (1 paper)BMC Medicine (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Fuchao Ma
25 papers receiving 400 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 223
- Molecular Biology 319
- Hepatology 23
- Oncology 60
- Pulmonary and Respiratory Medicine 50
Countries citing papers authored by Fuchao Ma
This map shows the geographic impact of Fuchao Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuchao Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuchao Ma more than expected).
Fields of papers citing papers by Fuchao Ma
This network shows the impact of papers produced by Fuchao Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuchao Ma. The network helps show where Fuchao Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Fuchao Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 68 | |
| 2 | 2018 | 49 | |
| 3 | 2011 | 35 | |
| 4 | 2011 | 27 | |
| 5 | 2020 | 25 | |
| 6 | 2019 | 23 | |
| 7 | 2022 | 20 | |
| 8 | 2018 | 20 | |
| 9 | 2018 | 16 | |
| 10 | 2017 | 15 | |
| 11 | 2018 | 14 | |
| 12 | 2018 | 13 | |
| 13 | 2020 | 12 | |
| 14 | Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma. | 2019 | 12 |
| 15 | 2019 | 12 | |
| 16 | 2013 | 10 | |
| 17 | 2019 | 7 | |
| 18 | The clinicopathological significance of decreased miR-125b-5p in hepatocellular carcinoma: evidence based on RT-qPCR, microRNA-microarray, and microRNA-sequencing. | 2019 | 5 |
| 19 | Clinicopathological significance of ribosomal protein S6 kinase A6 in lung squamous cell carcinoma: an immunohistochemical and RNA-seq study. | 2018 | 5 |
| 20 | 2017 | 4 |
About Fuchao Ma
Fuchao Ma is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Hepatology, having authored 25 papers that have together received 407 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (8 papers), MicroRNA in disease regulation (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Ferroptosis and cancer prognosis (4 papers), RNA Research and Splicing (4 papers), Circular RNAs in diseases (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (223 citations), Molecular Biology (319 citations), Hepatology (23 citations), Oncology (60 citations) and Pulmonary and Respiratory Medicine (50 citations). Fuchao Ma has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Gang Chen, Rong‐Quan He, Xiaohua Hu, Zu-yun Li, Dandan Xiong, Lu Liang, Dianzhong Luo, Peng Lin, Li Gao and Jie Ma. Their work appears in journals such as Oncology Reports, PeerJ, Acta Pharmaceutica Sinica B, Medicine and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.